Anthropometric measurements and clinical data, pre- and post-treatment in all groups.

Table 1: Anthropometric measurements and clinical data, pre- and post-treatment in all groups.

Supplemented group (SG)					Non-supplemented group (NG)
Variable		CTSG (n = 48)	ATSG (n = 67)	MFSG (n = 51)	CT (n = 52)	AT (n = 79)	MF (n = 48)	Statistical analysis	F	P
Age (years)	pre	66 ± 6	70 ± 6	66 ± 4	66 ± 5	67 ± 5	66 ± 4		2.34	0.09
BMI (Kg/m²)	pre	29.36 ± 5.14	29.66 ± 4.53	27.91 ± 4.36	28.64 ± 4.85	28.69 ± 4.33	26.65 ± 4.11	interaction	2.12	0.48
	pos	29.19 ± 5.16	29.56 ± 4.37	27.78 ± 4.32	28.75 ± 4.86	28.49 ± 4.73	26.55 ± 4.21	effect time 25(OH)D	1.49	0.59
25(OH)D (ng/ml)	pre	10.86 ± 2.26	12.06 ± 2.64	13.01 ± 3.43	22.60 ± 5.85	25.14 ± 6.12	26.16 ± 6.04	interaction	3.15	0.21
	pos	38.30 ± 13.77^**	39.42 ± 13.82^**	37.36 ± 10.46^**	24.87 ± 8.32	29.01 ± 8.86^**	32.24 ± 15^**	effect time 25(OH)D	199.34	< 0.001^*
Ca⁺⁺ (g)	pre	9.78 ± 0.42	9.69 ± 0.48	9.83 ± 0.43	9.88 ± 0.53	9.69 ± 0.49	9.73 ± 0.46	interaction	0.33	0.92
	pos	9.89 ± 0.53	9.76 ± 0.47	9.96 ± 0.59	9.91 ± 0.62	9.66 ± 0.44	9.71 ± 0.67	effect time 25(OH)D	0.10	0.15
PTH (pg/ml)	pre	49.12 ± 22.30	50.16 ± 17.53	42.49 ± 14.15	39.32 ± 14.29	38.99 ± 11.92	38.69 ± 11.98	interaction	1.29	0.27
	pos	38.66 ± 14.87	47.09 ± 18.26	39.44 ± 11.97	42.94 ± 18.31^**	42.30 ± 18.60	42.03 ± 17.15	effect time 25(OH)D	10.49	< 0.001^*